Overview

This reference text provides a detailed depiction of the nanoplatforms used for cancer nanovaccines. The book sums up the accomplishments that have been made in the advancement of the use of nanomaterials for cancer nanovaccines, and discusses their attributes and future perspectives. In summary, the book directly addresses all characterizations, syntheses, mechanisms, types, challenges, and clinical perspectives of nanoplatforms in cancer vaccines, in a comprehensive and multidisciplinary manner. The book also includes a thorough discussion on the efforts being made through genetic engineering to ‘personalize’ cancer nanovaccines. Key Features Focuses on the different types of nanotechnology used for cancer nanovaccines. Incorporates practical research and clinical studies on the mechanisms of vaccine throughout the book, with case studies. Discusses the latest developments in engineering of nanomaterials-based cancer vaccines. Provides thorough coverage on the characterization and synthesis of nanomaterials for vaccine delivery. Covers the challenges and opportunities for the rational design of nanotechnology for cancer nanovaccines. Discusses ethical and regulatory challenges, with emphasis on the EU, North America, Japan and other developing countries.

Full Product Details

9780750358927

Table of Contents

Reviews

Author Information

Dr. Nanasaheb Thorat is a Senior Principal Investigator at the Limerick Digital Cancer Research Center and the Department of Physics at the University of Limerick. He is also an Adjunct Scientist in the Medical Sciences Division, Department of Oncology, University of Oxford. He has been the recipient of seven major research grants in cancer nanomedicine since 2015. He has published 125 peer-reviewed journal articles, authored/edited nine books (Elsevier, Springer and IOPP) and written 21 book chapters. He has an h-index factor of 44.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available